Cogentix Medical, Inc.
CGNT
CGNT was delisted on the 20th of April, 2018.
34 hedge funds and large institutions have $14M invested in Cogentix Medical, Inc. in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 2 closing their positions.
80% more capital invested
Capital invested by funds: $7.76M → $14M (+$6.25M)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
3% more funds holding
Funds holding: 33 → 34 (+1)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$246K |
| 2 |
EEG
E.E. Geduld
|
+$163K |
| 3 |
Renaissance Technologies
New York
|
+$142K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$40.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$27.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$542K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$278K |
| 3 |
O
OrbiMed
New York
|
-$146K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$55.4K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$47.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FWM
26
Focused Wealth Management
Newburgh,
New York
| $6K | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $6K | +$2.59K | +2,004 | +144% |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
29
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $2K | – | – | – |
|
30
Bank of America
Charlotte,
North Carolina
| $1K | -$36 | -28 | -4% |
|
|
GC
31
Globeflex Capital
San Diego,
California
| $1K | – | – | – |
|
|
RC
32
RBF Capital
San Francisco,
California
| – | -$24K | -24,500 | Closed |
|
33
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | +$311 | +240 | New |
|
CGNT Hedge Fund Activity: Q3 2016 in Review
34 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q3 2016, worth a combined $14M — up 80% from $7.76M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CGNT positions and 2 closed out — a net gain of 1 holder — while 8 added to existing stakes and 11 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $246K. The largest seller was Perceptive Advisors, cutting an estimated $542K.
- 34 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q3 2016, up from 33 in Q2 2016.
- Funds reported $14M of Cogentix Medical, Inc. stock for Q3 2016, up 80% quarter-over-quarter.
- 3 funds opened new Cogentix Medical, Inc. positions in Q3 2016 and 2 closed out, a net change of +1 holder.
- The largest Cogentix Medical, Inc. buyer in Q3 2016 was Nantahala Capital Management, an estimated $246K added.
- The largest Cogentix Medical, Inc. seller in Q3 2016 was Perceptive Advisors, an estimated $542K sold.
Based on aggregated 13F filings for Q3 2016.